# ProLivRx: A New Approval in Depression

Page: https://stenobird.com/podcast/the-carlat-psychiatry-podcast-491560/prolivrx-a-new-approval-in-depression
Text version: https://stenobird.com/podcast/the-carlat-psychiatry-podcast-491560/prolivrx-a-new-approval-in-depression.md
Podcast: [The Carlat Psychiatry Podcast](https://stenobird.com/podcast/the-carlat-psychiatry-podcast-491560)
Published: 2026-01-19T07:00:00+00:00
Episode link: https://www.thecarlatreport.com/blogs/2-the-carlat-psychiatry-podcast/post/5826-prolivrx-a-new-approval-in-depression
Audio file: https://media.blubrry.com/the_carlat_psychiatry_podcast/content.blubrry.com/the_carlat_psychiatry_podcast/A_New_Approval_for_Depression_Edit_V2.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-carlat-psychiatry-podcast-491560/episodes/prolivrx-a-new-approval-in-depression
Duration seconds: 1250

## Resource

We interview Linda Carpenter, lead investigator on the new FDA approved device for difficult-to-treat depression. CME: Take the CME Post-Test for this Episode Published On: 01/19/2026 Duration: 20 minutes, 49 seconds Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-carlat-psychiatry-podcast-491560/episodes/prolivrx-a-new-approval-in-depression/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-carlat-psychiatry-podcast-491560/prolivrx-a-new-approval-in-depression.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.